DrugDashboards

Eltrombopag olamine

Eltrombopag olamine · ELTROMBOPAG OLAMINE 25 mg/1 · Tablet, Film Coated · Siegfried Barbera, SL

NDC 81719-0005-01 · 1 BAG in 1 DRUM / 71000 TABLET, FILM COATED in 1 BAG · DRUG FOR FURTHER PROCESSING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 00078-0685-15) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of saleⓘ
$247.70per unit
middle half $245.51–$251.23 · 1,070 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $247.70
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
19%of plans cover it
tier 5 · prior auth 100% · step therapy 0% · qty limit 100%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $14,664.12 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
—
TE code
—
Approval date
—
Patents / exclusivity
—

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Eltrombopag olamine (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Amerisyn, LLCELTROMBOPAG OLAMINE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Amerisyn, LLCELTROMBOPAG OLAMINE 25 mg/1Jul 15, 2026Sep 2, 2026
Amerisyn, LLCELTROMBOPAG OLAMINE 50 mg/1Jul 15, 2026Sep 2, 2026
Amerisyn, LLCELTROMBOPAG OLAMINE 75 mg/1Jul 15, 2026Sep 2, 2026
Glaxo Operations UK LtdELTROMBOPAG OLAMINE 25 mg/1Jul 15, 2026Sep 2, 2026
Glaxo Operations UK LtdELTROMBOPAG OLAMINE 50 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCELTROMBOPAG OLAMINE 75 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCELTROMBOPAG OLAMINE 50 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCELTROMBOPAG OLAMINE 25 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCELTROMBOPAG OLAMINE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Novartis Pharmaceuticals CorporationELTROMBOPAG OLAMINE 75 mg/1Jul 15, 2026Sep 2, 2026
Novartis Pharmaceuticals CorporationELTROMBOPAG OLAMINE 25 mg/1Jul 15, 2026Sep 2, 2026
Novartis Pharmaceuticals CorporationELTROMBOPAG OLAMINE 50 mg/1Jul 15, 2026Sep 2, 2026
Novartis Pharmaceuticals CorporationELTROMBOPAG OLAMINE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Siegfried Barbera, SLELTROMBOPAG OLAMINE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Siegfried Barbera, SLELTROMBOPAG OLAMINE 25 mg/1Jul 15, 2026Sep 2, 2026
Siegfried Barbera, SLELTROMBOPAG OLAMINE 75 mg/1Jul 15, 2026Sep 2, 2026
Siegfried Barbera, SLELTROMBOPAG OLAMINE 50 mg/1Jul 15, 2026Sep 2, 2026
Somerset Therapeutics, LLCELTROMBOPAG OLAMINE 75 mg/1Jul 15, 2026Sep 2, 2026
Somerset Therapeutics, LLCELTROMBOPAG OLAMINE 50 mg/1Jul 15, 2026Sep 2, 2026
Somerset Therapeutics, LLCELTROMBOPAG OLAMINE 25 mg/1Jul 15, 2026Sep 2, 2026
Somerset Therapeutics, LLCELTROMBOPAG OLAMINE 12.5 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Eltrombopag olamine — NDC 81719-0005-01," retrieved September 3, 2026, https://drugdashboards.com/drug/81719000501.

Free to cite with attribution — see how the data is put together.